idiopathic%20pulmonary%20fibrosis
IDIOPATHIC PULMONARY FIBROSIS

Idiopathic pulmonary fibrosis is the progressive parenchymal scarring & loss of pulmonary function due to unidentifiable cause of lung injury.

It is a specific form of chronic fibrosing interstitial pneumonia with the histopathologic characteristics of usual interstitial pneumonia.

Approximately 5% of patients are asymptomatic. Common signs and symptoms are exertional dyspnea, nonproductive cough, finger clubbing and bilateral inspiratory crackles.

Supportive Therapy

  • Supportive measures in patients with acute exacerbation of idiopathic pulmonary fibrosis should include relief of dyspnea & provision of supplemental oxygen

Anti-Acid Therapy

  • Acid aspiration & gastroesophageal reflux/gastroesophageal reflux disease causing acute exacerbation of idiopathic pulmonary fibrosis may be treated with antacids (ie proton pump inhibitors, histamine-2 blocker receptor antagonists)
    • May help reduce the risk for microaspiration-associated lung injury 
  • Stress ulcer prophylaxis guidelines must be followed

Antibiotics

  • May be considered in idiopathic pulmonary fibrosis patients in acute exacerbation with radiographic findings of overlapping pneumonia
  • If the culture is negative, a 7-day course of antibiotic is recommended

Symptom Control for Cough & Dyspnea

  • Facial cooling with a fan & the use of opioids & anxiolytics may help alleviate refractory cough & dyspnea

Prevention of Venous Thromboembolism (VTE)

  • Venous thromboembolism is common in patients who were hospitalized due to acute exacerbation of idiopathic pulmonary fibrosis & routine measures should be employed

Vaccine

  • Influenza & pneumococcal vaccines should be offered to patients with idiopathic pulmonary fibrosis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 10 Jan 2018
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
22 May 2017
Chronic obstructive pulmonary disease (COPD) is currently the 10th commonest cause of death in Singapore, with a disease burden of 5.9 percent according to a 2015 population-based survey (EPIC-Asia survey) in Singapore. Pearl Toh spoke with Dr Augustine Tee, chief and senior consultant of the Department of Respiratory and Critical Care Medicine at Changi General Hospital (CGH) in Singapore, on how COPD is often underdetected in the primary care population as symptoms are not specific and diagnosis requires a combination of clinical risk factors, symptoms and spirometry testing.
Pearl Toh, 24 Oct 2019
Using e-cigarettes can lead to cellular inflammation in the lungs among healthy adults who had never smoked, even with use as short as 4 weeks, suggests a pilot study.
Roshini Claire Anthony, 30 Oct 2019

Combining a nicotine patch plus a nicotine e-cigarette could potentially boost the likelihood of smoking cessation in adults aiming to quit smoking, according to a study from New Zealand.